MktsMarkets

Ardent Health, Inc.
NYSE: ARDTKey statistics
ARDT News
Stories mentioning ARDT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,601,870 | 1,605,079 | 1,576,746 | 1,645,280 | 1,497,234 | 1,606,289 | 1,449,817 | 1,470,920 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 74,591 | 92,371 | (2,203) | 121,992 | 74,198 | 167,246 | 57,067 | 82,183 |
| Tax Provision | 16,103 | 18,109 | (3,410) | 26,291 | 15,233 | 26,355 | 11,062 | 15,222 |
| Net Income (Loss) | 39,850 | 44,956 | (23,478) | 72,950 | 41,383 | 114,204 | 26,322 | 42,770 |
| Earnings Per Share (Basic) | 0.28 | 0.32 | (0.17) | 0.52 | 0.30 | 0.86 | 0.19 | 0.34 |
| Earnings Per Share (Diluted) | 0.28 | 0.32 | (0.17) | 0.52 | 0.29 | 0.86 | 0.19 | 0.34 |
| Weighted Average Shares Outstanding (Basic) | 141,266 | 140,761 | 141,227 | 140,375 | 140,062 | 132,440 | 137,108 | 126,115 |
| Weighted Average Shares Outstanding (Diluted) | 141,775 | 141,450 | 141,227 | 141,518 | 140,704 | 132,745 | 137,543 | 126,115 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ARDT
Ardent Health, Inc. (NYSE: ARDT) is a stock listed on the New York Stock Exchange under the ticker symbol ARDT. It last traded at $17.30 (Nov 6, 2026, 4:00 PM ET), up 8.8% on the day. That gives Ardent Health a market capitalisation of $2.4B and a price-to-earnings ratio of 31.2.
Over the past 52 weeks ARDT has traded between $7.71 and $17.68.
Revenue for the quarter ended Mar 31, 2026 was $1.6B; net income $39.9M. Revenue was up 7.0% from $1.5B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.6B | $39.9M | 2.5% |
| Dec 31, 2025 | $1.6B | $45.0M | 2.8% |
| Sep 30, 2025 | $1.6B | -$23.5M | -1.5% |
| Jun 30, 2025 | $1.6B | $73.0M | 4.4% |
From Ardent Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…